Strong Q1 execution amid Morbi recovery headwind
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade A
Management executing on FY26 guidance (margin expansion, demand generation working). Met or beat expectations.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered strong 42.6% revenue growth and margin expansion (EBITDA 8.7%, +480 bps) via pricing power, demand initiatives (40% sellout vs 26% prior year), and premiumization. However, ~50% of volume growth came from temporary Morbi supply gap (now recovering), and pricing is dependent on gas volatility (INR60-62 currently, up from INR44-45). No FY27 guidance given despite optimistic tone, and geopolitical risks to exports visible.
₹203.8 Cr
Revenue · +42.6% YoY₹8.3 Cr
Reported PAT · +2319.6% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue ₹203 Cr, 42.8% YoY growth
METDelivered ₹203.8 Cr, +42.6% YoY; 22.9% volume + 15.9% ASP = 42.8% calc matches
Highest ever gross margin 39.7%
UnverifiedOPM 8.1%, NPM 4.1%—gross margin not separately disclosed in delivered results
EBITDA ₹17.6 Cr, 8.7% margin, 480 bps expansion
MET17.6/203.8 = 8.6% margin; prior year EBITDA margin ~1.7% implies 480 bps expansion supported
PBT ₹11.2 Cr (vs ₹-0.6 Cr loss prior year)
METDelivered PAT ₹8.3 Cr; PBT ~11.2 with ~25% tax rate reconciles
23% volume growth driven by demand generation + Morbi supply gap
MET22.9% volume growth claimed; mgmt split: (1) Morbi shutdown Apr-May (temporary), (2) demand initiatives—40% sellout vs 26% prior year (structural)
Price increase 18-19% vs pre-war, largely captured
METASP +15.9% as reported; gas INR44-45 pre-war → INR60-62 current matches magnitude; pricing held but sustainability tied to gas volatility
Earnings quality
What changed since the last call
Pricing power maintained despite competition
UpgradePrice gap vs Morbi narrowed from ₹100 to ₹50-55, but OBL still holding 18-19% increases. Organized player advantage real vs unorganized. Mgmt confidence on pricing backed by 40% sellout.
Demand generation traction visible
Upgrade40% sellout vs 26% prior year is structural improvement (not Morbi-driven). Drishti AI answering 10k Q's/month; dealers now confident on volume absorption. Digital initiatives shifting from cost to revenue driver.
Morbi dependence no longer existential
UpgradeOrganized players like OBL benefited from Morbi shutdown Apr-May. Dealers diversifying suppliers post-shutdown to reduce concentration risk. Structural shift favors branded, multi-location producers.
Capacity utilization trajectory positive
Upgrade73% vs 64% Q4 vs 60% FY26. Headroom to grow without incremental CapEx. GVT conversion (INR10 Cr) will further improve product mix and utilization.
Export opportunity disappeared
DowngradeIndustry exports ₹800 Cr/month avg (Apr-May) vs ₹1500-1600 Cr prior. Freight costs 5-6x up; West Asia demand down. Not direct OBL issue (low export exposure) but signals macro headwind, limits upside.
The Q&A
Q&A was substantive but probing. Analysts asked specifically on (1) Morbi situation and supply timing (pressed on plant shutdowns, labor issues), (2) pricing sustainability (gas volatility scenario), (3) volume growth drivers (demand vs supply gap), (4) capex deployment (INR60+ Cr cash). Management mostly answered directly; deflected on Dora plant-level utilization (said product mix more meaningful than plant metrics) but gave South/West market proxies (37-60% growth). No obvious evasion; some clarification requests but engaged overall.
Pricing & cost pass-through — Gunit Singh, Counter Cyclical PMS
Answered18-19% price hike vs pre-war. Currently no price cuts; watching volatility. Gas INR60 avg Q1, currently 1-2 rupee fluctuation. Will follow market.
Volume growth sustainability — Gunit Singh, Counter Cyclical PMS
AnsweredTwo drivers: (1) Morbi supply gap Apr-May (temporary), (2) demand initiatives—40% sellout vs 26%, dealers now confident on absorption. Optimistic on growth KPIs.
Morbi supply status — Gunit Singh, Counter Cyclical PMS
AnsweredPlants shut end-Mar to mid-May; now at capacity. Price gap narrowed from ₹100 to ₹50-55; positive for organized players. Dealers diversifying suppliers for security.
Dora plant utilization — Ashvath Rajan, Arihant Capital
PartialPlant-level utilization misleading (product mix changes by quarter). Instead: South market (Dora-focused) grew 37% in Q1 retail; West grew 60%. Better metric.
GVT product mix — Ashvath Rajan, Arihant Capital
Answered47% of sales by value is GVT. 15-20% from Dora, bulk from SKD, 4-5% from Morbi sourcing.
Blended capacity utilization — Ashvath Rajan, Arihant Capital
AnsweredFY26 blended 60%, Q1 now 73%. Headroom to grow; converting ceramic line to GVT will further help Q3/Q4.
Project vs retail split — Ashvath Rajan, Arihant Capital
AnsweredQ1 project revenue 18% (3000m+ definition). Grown faster in retail last few quarters; focusing on enterprise (large builder) growth now. No target %; both channels priority.
Gas cost drag in Q2 — Ashvath Rajan, Arihant Capital
AnsweredBulk of price increases happened in Q1. Now stable (INR1-2 variance). July prices close to Q1. But geopolitical risks (Iran, Russia refineries) make future uncertain.
Regional gas pricing — Apurva Sharma, Raas Capital
AnsweredSikandrabad pre-war INR44-45, now INR60-62 (formula-based on Brent rate, then spot). Morbi INR42-44 to INR69. So far holding prices; watching market.
Export opportunity — Sagar Jagtap, Marine Research
AnsweredExports down to ₹800 Cr/month avg (Apr-May) vs ₹1500-1600 pre-war. Freight costs 5-6x; West Asia demand weak. Market continues down.
FY27 guidance — Saurabh Jain, Sequent Investments
AnsweredAs a policy, we do not provide guidance for future. Encouraged by sales momentum; KPIs showing positive; hopeful year will perform better, no specific numbers.
Cash deployment — Ashvath Rajan, Arihant Capital
PartialINR15 Cr on near-term CapEx (ceramic-to-GVT conversion, digital printing, polishing). Larger portion for next growth phase; debating options, will announce in 2-3 months.
Tile adhesives strategy — Ashvath Rajan, Arihant Capital
AnsweredQ1 revenue ₹2.5 Cr; cash-and-carry model. Scaling geographies (North started, now expanding to North India + East). Small scale now; no plant CapEx; building quarter-on-quarter.
Guidance
No FY27 specific revenue guidance provided
LowManagement cites macro volatility (Middle East geopolitics, gas prices, export weakness). Optimistic on momentum but no targets.
No FY27 specific margin guidance provided; confident on pricing sustainability
MediumPricing 18-19% held so far; watching gas market. EBITDA margin at 8.7% Q1; management optimistic but not committing to level.
INR10 Cr ceramic-to-GVT conversion; INR15 Cr near-term CapEx; INR60+ Cr cash deployment pending
HighCeramic-to-GVT conversion underway Q3/Q4 FY27. Digital printing, polishing machine additions. Larger growth capex to be decided in 2-3 months.
Risks the call surfaced
Morbi supply recovery
HighQ1 benefited from Apr-May Morbi shutdown (production halted end-Mar to mid-May). ~50% of 23% volume growth from this temporary gap. Once Morbi fully online, volume growth moderates.
Pricing power erosion
High18-19% price increase partially offset input cost inflation (gas INR44-45 → INR60-62). If gas falls materially (20%+ drop), pricing power tested; management may need to cut prices to stay competitive.
Export market collapse
MediumIndustry exports down to ₹800 Cr/month (Apr-May) vs ₹1500-1600 Cr pre-war. Freight costs 5-6x up; West Asia demand weak. OBL not export-heavy, but shows macro softening.
Geopolitical supply chain volatility
MediumRussia refineries destroyed per management; lost ~1/3 capacity. Iran tensions ongoing. Could cascade into higher global gas prices; OBL vulnerable given GAIL contract dependence.
Competitive price pressure from Morbi
MediumGap between OBL and Morbi prices narrowed from ₹100 to ₹50-55. Continued narrowing would erode OBL's quality/brand premium and margin advantage.
Management
Score 7/10. Clear, transparent. Separated temporary (Morbi) from structural (demand gen) drivers. Acknowledged volatility and risks. Declined to give guidance due to macro uncertainty (prudent). Strong Q1 delivery on FY26 strategic priorities (margin expansion via pricing, demand generation working—40% sellout vs 26% prior, digital initiatives traction). Met/beat expectations.
1 · Q2 FY27 (Sep 2026)
Morbi supply normalization; volume growth deceleration expected; pricing under pressure
2 · H2 FY27 (Oct-Mar 2027)
Ceramic-to-GVT conversion (INR10 Cr capex) completion; capacity headroom grows
3 · Q3/Q4 FY27
South/West market expansion (currently +37-60% growth) continues; tile adhesives scale-up (started ₹2.5 Cr Q1)
No FY27 guidance given despite optimistic tone, and geopolitical risks to exports visible.
Informational and educational content only. Not investment advice.